(lp0
S'Better Buy: Organovo Holdings, Inc. vs. United Therapeutics Corporation Motley Fool - Feb 22, 2017 Pitting Organovo Holdings  against United Therapeutics  might seem a bit strange. Organovo is much smaller than United Therapeutics. Their products have little in common. However, both of these healthcare stocks have&nbsp;...United Therapeutics  Q4 2016 Results - Earnings Call Transcript - Seeking Alpha'
p1
aS'United Therapeutics Reaches Analyst Target Price Nasdaq - Mar 20, 2017 In recent trading, shares of United Therapeutics Corp  have crossed above the average analyst 12-month target price of $140.80, changing hands for $142.08/share.Analyst Upside Underscores Impressive Growth for United Therapeutics ... - Aiken AdvocateThe Credit Suisse Group AG Begins Coverage on United Therapeutics Co.  - Petro Global News 24'
p2
aS'Credit Suisse Starts United Therapeutics Corp.  at Underperform StreetInsider.com - Mar 16, 2017 Credit Suisse initiates coverage on United Therapeutics Corp.  with a Underperform rating and a price target of $120.00.United Therapeutics Corporation  Moves Lower on Volume Spike for March 16 - Equities.comAnalyst Activity  Credit Suisse Group AG Initiates Coverage On United ... - Market Exclusive'
p3
aS'United Therapeutics Corporation To Present At Barclays Global Healthcare ... PR Newswire  - Mar 7, 2017 SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 7, 2017 /PRNewswire/ -- United Therapeutics Corporation  announced today that Martine Rothblatt, Ph.UPDATE: Jefferies Downgrades United Therapeutics Corp.  to Underperform - StreetInsider.comUnited Therapeutics Corp  Files Form 4 Insider Selling : Martine A ... - Energy Index'
p4
aS'United Therapeutics feels squeeze from increased pulmonary hypertension ... Washington Business Journal - Feb 23, 2017 United Therapeutics Corp.  blames increasing competition in the pulmonary arterial hypertension space for its lower-than-expected revenue last year, CEO Martine Rothblatt told analysts Wednesday.'
p5
aS'Narrowing in on the Numbers for United Therapeutics Corporation  Rives Journal - 15 hours ago United Therapeutics Corporation  has an EV  of 5457492. Enterprise Value measures the complete value of a specific company.'
p6
aS"Northwell Health and United Therapeutics Announce Strategic Partnership to ... PR Newswire  - Mar 9, 2017 MANHASSET, N.Y. and SILVER SPRING, Md., March 9, 2017 /PRNewswire/ -- Northwell Health's Feinstein Institute for Medical Research and United Therapeutics Corporation  announced today a strategic partnership focused on the&nbsp;...Northwell, drug-maker ink bioelectronics partnership - Innovate Long Island"
p7
aS"United Therapeutics Corporation To Present At Cowen And Company 37th Annual ... PR Newswire  - Feb 28, 2017 28, 2017 /PRNewswire/ -- United Therapeutics Corporation  announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the&nbsp;..."
p8
aS"Is United Therapeutics a Great Stock for Value Investors? Yahoo Finance - Mar 21, 2017 This level actually compares pretty favorably with the market at large, as the PE for the S&amp;P 500 compares in at about 20.48. If we focus on the stock's long-term PE trend, the current level puts United Therapeutics' current PE ratio below its midpoint ..."
p9
aS'Credit Suisse negative on United Therapeutics; shares slip 4% Seeking Alpha - Mar 16, 2017 United Therapeutics  goes south on modestly higher volume on the heels of an Underperform rating and $120  price target by Credit Suisse.'
p10
a.